Novo Nordisk To Cut Ozempic, Wegovy Prices By Up To 50%

• Novo Nordisk stated that its price cuts for Ozempic and Wegovy are intended to benefit insured patients.
• The company said this will also benefit patients who pay out of pocket, but their costs are tied to the list price of these drugs.
• Novo Nordisk said this applies to patients with high-deductible health plans or co-insurance benefit designs.

Novo Nordisk AS (NVO) is planning to cut Ozempic and Wegovy prices in the U.S. by up to 50% starting in 2027.

Ozempic and Wegovy prices will start at a list price of $675 a month, effective Jan. 1, 2027, according to the company. This is a 50% reduction when compared to the current list price of Wegovy, and about 35% cut for the list price of Ozempic.

“Lowering the list price of Wegovy and Ozempic is the best approach to address the unprecedented opportunity to help more than 100 million people living with obesity and over 35 million people with type 2 diabetes in the United States,” said Jamey Millar, Novo Nordisk’s Executive Vice President of U.S. operations.

Novo Nordisk shares were down nearly 2% in Tuesday’s opening trade. Retail sentiment on Stocktwits around the company trended in the ‘bullish’ territory with message volumes at ‘extremely high’ levels at the time of writing.

Who Will Benefit From These Lower Prices?

Novo Nordisk stated that its price cuts for Ozempic and Wegovy are intended to benefit insured patients.

This will also benefit patients who pay out of pocket, but whose costs are linked to the list price of these drugs. This applies to patients with high-deductible health plans or co-insurance benefit designs, the company said.

Novo Nordisk added that Tuesday’s price cuts do not impact its direct-to-consumer and self-pay offerings of Ozempic and Wegovy.

Ozempic And Wegovy Prices For Cash-Paying Patients

Novo Nordisk currently offers Wegovy for cash-paying patients, starting at $149 per month for the pill and $199 per month for the pen.

Ozempic prices start at $199 a month for the first two months for new patients for 0.25 mg and 0.5 mg doses.

Existing patients can get Ozempic in 0.25 mg, 0.5 mg, and 1 mg doses at $349 per month.

All patients will have to pay $499 a month for the 2 mg dose of Ozempic.

NVO stock is down 24% year-to-date and 56% over the past 12 months.

Also See: AMD Stock Soars Pre-Market After Meta Expands Multi-Year AI Chip Partnership

For updates and corrections, email newsroom[at]stocktwits[dot]com.

Share

·

Add us on